According to Neuren Pharmaceuticals's latest financial reports the company's total assets are โน14.45 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | โน14.06 B | 477.25% |
2022-12-31 | โน2.43 B | 12.72% |
2021-12-31 | โน2.16 B | 54.04% |
2020-12-31 | โน1.40 B | 95.09% |
2019-12-31 | โน0.71 B | -45.19% |
2018-12-31 | โน1.31 B | 46.72% |
2017-12-31 | โน0.89 B | 194.06% |
2016-12-31 | โน0.30 B | -62.83% |
2015-12-31 | โน0.81 B | -28.63% |
2014-12-31 | โน1.14 B | -21.23% |
2013-12-31 | โน1.45 B | 201.6% |
2012-12-31 | โน0.48 B | -20.1% |
2011-12-31 | โน0.60 B | 132.13% |
2010-12-31 | โน0.26 B | -39.3% |
2009-12-31 | โน0.42 B | 47.95% |
2008-12-31 | โน0.28 B | -42.1% |
2007-12-31 | โน0.50 B | -26.58% |
2006-12-31 | โน0.68 B | -41.19% |
2005-12-31 | โน1.15 B | 166.84% |
2004-12-31 | โน0.43 B | |
2003-12-31 | N/A | |
2002-12-31 | N/A |